The aberrant expression of FCRL3 in autoimmune thyroid diseases, Grave’s disease, systemic lupus erythematosus (LES), and pSS has already been noted [62,63], while its exact function in pSS is not clear yet. This evidence concerns the gene FCRL3 and peeling skin syndrome.